# Phase 1 stroke trials recruiting: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 1 for stroke that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 stroke trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/stroke

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07913282 | ARTEMIS: Umbilical Cord-Derived Mesenchymal Stromal Cells (UC-MSCs) After Mechanical Thrombectomy for Acute Ischemic Stroke | Royan Stem Cell Technology Company | Phase 1 | Not yet recruiting | Acute Ischemic Stroke | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913282) |
| September 10, 2026 | NCT07813130 | A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke | Aruna Bio, Inc. | Phase 1 | Not yet recruiting | Acute Ischemic Stroke | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07813130) |
| June 5, 2026 | NCT07628933 | A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke | BOE Technology Group Co., Ltd. | Phase 1 | Not yet recruiting | Acute Ischemic Stroke, AIS | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628933) |
| March 27, 2026 | NCT07495722 | Safely Quenching Complement in Stroke Survivors | Columbia University | Phase 1 | Not yet recruiting | Acute Ischemic Stroke, Cerebral Infarction | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495722) |
| March 13, 2026 | NCT07469163 | Phase I Split-Belt Treadmill Dosing for Subacute Stroke | University of Calgary | Phase 1 | Recruiting | Subacute Stroke, Stroke, Stroke (Subacute), Stroke Gait Rehabilitation | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469163) |
| January 28, 2026 | NCT07371455 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants | Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | Phase 1 | Recruiting | Ischemic Stroke | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07371455) |
| November 18, 2025 | NCT07232563 | Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the... | Zhujiang Hospital | Phase 1 | Not yet recruiting | Ischemic Stroke | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07232563) |
| July 8, 2025 | NCT07053917 | Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability | Johns Hopkins University | Phase 1 | Recruiting | Stroke, Chronic Stroke, Intracerebral Haemorrhage, Intracerebral Haemorrhage (ICH), Intracerebral Hemorrhage Basal... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053917) |
| May 29, 2025 | NCT06995625 | The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA) | S&Ebio Co. Ltd. | Phase 1 | Recruiting | Acute Ischemic Stroke AIS | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06995625) |
| May 4, 2025 | NCT06956521 | Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke | Baylor College of Medicine | Phase 1 | Recruiting | Acute Ischemic Stroke | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956521) |
| April 22, 2025 | NCT06938243 | Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation | Qilu Hospital of Shandong University | Phase 1 | Recruiting | Stroke, Motor Rehabilitation | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06938243) |
| April 1, 2025 | NCT06905314 | A Single Ascending Dose of HRS-4029 in Healthy Subjects | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 1 | Not yet recruiting | Acute Ischemic Stroke | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06905314) |
| January 30, 2025 | NCT06801054 | Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose | Memorial Hermann Health System | Phase 1 | Not yet recruiting | Acute Ischemic Stroke | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06801054) |
| November 20, 2024 | NCT06696131 | Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH) | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Intracerebral Hemorrhage, Intracranial Hemorrhages, Hemorrhagic Strokes | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06696131) |
| November 8, 2024 | NCT06679998 | A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection | Jiangsu Kanion Pharmaceutical Co., Ltd | Phase 1 | Not yet recruiting | Acute Ischemic Stroke (AIS) | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06679998) |
| October 29, 2024 | NCT06663631 | Study on Hibernation-like Therapy Based on Mechanical Thrombectomy | Capital Medical University | Phase 1 | Recruiting | Acute Ischemic Stroke | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06663631) |
| September 25, 2024 | NCT06612710 | The Safety and Efficacy of NouvSoma001 in Ischemic Stroke | Sponsor not shown (see the record) | Phase 1 | Recruiting | Ischemic Stroke | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06612710) |
| April 15, 2024 | NCT06365099 | Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke | University of Texas at Austin | Phase 1 | Recruiting | Stroke | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06365099) |
| February 28, 2024 | NCT06280482 | Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS) | The University of Texas Health Science Center, Houston | Phase 1 | Recruiting | Smooth Muscle Dysfunction Syndrome (SMDS) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06280482) |
| May 23, 2023 | NCT05871606 | Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy | Wake Forest University Health Sciences | Phase 1 | Recruiting | Cerebrovascular Disorders, Acute Cerebrovascular Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05871606) |
| December 15, 2021 | NCT05158101 | Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for Stroke | The Foundation for Orthopaedics and Regenerative Medicine | Phase 1 | Recruiting | Stroke | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05158101) |
| November 16, 2020 | NCT04630873 | Low or High Botox Dilution for the Hemiplegic Gait? | University of Ioannina | Phase 1 | Recruiting | Post Stroke Spastic Hemiplegia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04630873) |
| April 2, 2019 | NCT03899298 | Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions | R3 Stem Cell | Phase 1 | Not yet recruiting | Orthopedic Disorder, Neurologic Disorder, Urologic Diseases, Erectile Dysfunction, Autoimmune Diseases, Renal Failure... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03899298) |
| June 27, 2018 | NCT03570450 | Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1 | University Hospital, Grenoble | Phase 1 | Recruiting | Stroke | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03570450) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Columbia University | 1 |
| Memorial Hermann Health System | 1 |
| University of Calgary | 1 |
| University Hospital, Grenoble | 1 |
| [Beijing Suncadia Pharmaceuticals Co., Ltd](https://specstream.ai/data/clinical-trials/company/beijing-suncadia-pharmaceuticals-co-ltd) | 1 |
| Baylor College of Medicine | 1 |
| S&Ebio Co. Ltd. | 1 |
| Wake Forest University Health Sciences | 1 |
| University of Ioannina | 1 |
| Qilu Hospital of Shandong University | 1 |
| University of Texas at Austin | 1 |
| R3 Stem Cell | 1 |
| Royan Stem Cell Technology Company | 1 |
| Jiangsu Kanion Pharmaceutical Co., Ltd | 1 |
| Aruna Bio, Inc. | 1 |
| Johns Hopkins University | 1 |
| Zhujiang Hospital | 1 |
| BOE Technology Group Co., Ltd. | 1 |
| Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| Capital Medical University | 1 |
| The Foundation for Orthopaedics and Regenerative Medicine | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| China | 7 |
| Greece | 2 |
| Canada | 1 |
| France | 1 |
| South Korea | 1 |
| Iran | 1 |
| Australia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Cosmetology schools in the United States](https://specstream.ai/data/businesses/cosmetology-schools/united-states)
- [Physical therapy clinics in the United States](https://specstream.ai/data/businesses/physical-therapy-clinics/united-states)
- [Cabinet makers in the United States](https://specstream.ai/data/businesses/cabinet-makers/united-states)
- [Natural gas utilities in the United States](https://specstream.ai/data/businesses/natural-gas-utilities/united-states)
- [B2B power plants and power plant companies in the United States](https://specstream.ai/data/businesses/b2b-power-plants-and-power-plant-companies/united-states)
